NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Johnson & Johnson announced a quarterly dividend on Thursday, January 2nd. Stockholders of record on Tuesday, February 25th will be paid a dividend of $0.95 per share on Tuesday, March 10th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 2.56%. The ex-dividend date is Monday, February 24th. View Johnson & Johnson's Dividend History.

Johnson & Johnson declared that its board has initiated a share repurchase program on Monday, December 17th 2018, which authorizes the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 1.5% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.

Johnson & Johnson (NYSE:JNJ) issued its quarterly earnings data on Wednesday, January, 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.87 by $0.01. The company had revenue of $20.75 billion for the quarter, compared to analysts' expectations of $20.83 billion. Johnson & Johnson had a return on equity of 39.81% and a net margin of 21.09%. The business's quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.97 EPS. View Johnson & Johnson's Earnings History.

Johnson & Johnson issued an update on its FY20 earnings guidance on Wednesday, January, 22nd. The company provided EPS guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.09. The company issued revenue guidance of +4.5-5.5% yr/yr to $85.8-86.2 billion, compared to the consensus revenue estimate of $85.52 billion.

13 brokerages have issued 12-month target prices for Johnson & Johnson's stock. Their forecasts range from $145.00 to $173.00. On average, they expect Johnson & Johnson's stock price to reach $159.45 in the next twelve months. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Headlines about JNJ stock have been trending somewhat negative on Thursday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Johnson & Johnson earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Johnson & Johnson.

Johnson & Johnson saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 20,870,000 shares, an increase of 21.3% from the November 28th total of 17,210,000 shares. Based on an average daily volume of 7,440,000 shares, the short-interest ratio is presently 2.8 days. Approximately 0.8% of the shares of the company are sold short. View Johnson & Johnson's Current Options Chain.

Some companies that are related to Johnson & Johnson include Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), Pfizer (PFE), Intel (INTC), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and Home Depot (HD).

Johnson & Johnson's stock is owned by many different of retail and institutional investors. Top institutional investors include Johanson Financial Advisors Inc. (0.09%), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST (0.08%), Manning & Napier Group LLC (0.07%), Marathon Asset Management LLP (0.07%), PGGM Investments (0.05%) and DNB Asset Management AS (0.05%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Hubert Joly, Joaquin Duato, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed, Paulus Stoffels, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

JNJ stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., PGGM Investments, DNB Asset Management AS, Hexavest Inc., United Services Automobile Association, Commerzbank Aktiengesellschaft FI, Marathon Asset Management LLP and Meag Munich Ergo Kapitalanlagegesellschaft MBH. View Insider Buying and Selling for Johnson & Johnson.

JNJ stock was acquired by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Artemis Investment Management LLP, WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST, Hamlin Capital Management LLC, Empire Life Investments Inc., Bristol John W & Co. Inc. NY, Tandem Investment Advisors Inc. and Advisors Capital Management LLC. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince, Hubert Joly and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of JNJ stock can currently be purchased for approximately $148.25.

Johnson & Johnson has a market capitalization of $390.17 billion and generates $81.58 billion in revenue each year. The company earns $15.30 billion in net income (profit) each year or $8.18 on an earnings per share basis. Johnson & Johnson employs 135,100 workers across the globe.View Additional Information About Johnson & Johnson.

The official website for Johnson & Johnson is http://www.jnj.com/.

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.